High T-cell response to human cytomegalovirus induces chemokine-mediated endothelial cell damage

Blood

Volumn 110, Issue 6, 2007, Pages 1857-1863

  Bolovan Fritts, Cynthia A ^a   Trout, Rodney N ^a   Spector, Stephen A ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; FRACTALKINE; GAMMA INTERFERON; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL ADHESION; CELL DAMAGE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 34548831060     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-03-078881     Document Type: Article

References (36)

1. Mocarski ES Jr, Courcelle CT. Cytomegaloviruses and their replication. In: Knipe DM, Howley PM, eds. Field's virology. (4th ed.) Philadelphia, PA: Lippincott Williams & Wilkins; 2001:2629-2674.
2. Britt W. Human cytomegalovirus infections and mechanisms of disease. In: Reddehase MJ, ed. Cytomegaloviruses: molecular biology and immunology. Wymondham, Norfolk, United Kingdom: Caister Academic Press; 2006:1-28
3. Zhu J, Shearer GM, Norman JE, et al. Host response to cytomegalovirus infection as a determinant of susceptibility to coronary artery disease: sex-based differences in inflammation and type of immune response. Circulation. 2000;102:2491-2496.
4. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695.
5. Hansson GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol. 2001;21:1876-1890.
6. Pawelec G, Akbar A, Caruso C, Solana R, Grubeck-Loebenstein B, Wikby A. Human immunosenescence: is it infectious? Immunol Rev. 2005;205:257-268.
7. Speir E, Modali R, Huang ES, et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 1994;265:391-394.
8. Streblow DN, Kreklywich C, Yin Q, et al. Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants. J Virol. 2003;77:2182-2194.
9. Umehara H, Bloom E, Okazaki T, Domae N, Imai T. Fractalkine and vascular injury. Trends Immunol. 2001;22:602-607.
10. Zhou YF, Leon MB, Waclawiw MA, et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med. 1996;335:624-630.
11. Bruning JH, Persoons M, Lemström K, Stals FS, De Clercq E, Bruggeman CA. Enhancement of transplantation-associated atherosclerosis by CMV, which can be prevented by antiviral therapy in the form of HPMPC. Transpl Int. 1994;7(suppl 1):S365-S370.
12. Lunardi C, Bason C, Navone R, et al. Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med. 2000;6:1183-1186.
13. Streblow DN, Soderberg-Naucler C, Vieira J, et al. The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell. 1999;99:511-520.
14. Valantine HA, Gao SZ, Menon SG, et al. Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study. Circulation. 1999;100:61-66.
15. Pass RF. Cytomegalovirus. In: Knipe DM, Howley PM, eds. Field's virology (4th ed). Philadelphia, PA: Lippincott Williams & Wilkins; 2001:2675-2705.
16. Lemström K, Koskinen P, Krogerus L, Daemen M, Bruggeman C, Häyry P. Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts. Circulation. 1995;92:2594-2604.
17. Merigan TC, Renlund DG, Keay S, et al. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N Engl J Med. 1992;326:1182-1186.
18. Zhou YF, Shou M, Guetta E, et al. Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall. Circulation. 1999;100:1569-1575.
19. Lemström KB, Bruning JH, Bruggeman CA, Lautenschlager IT, Häyry PJ. Triple drug immunosuppression significantly reduces immune allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection. Am J Pathol. 1994;144:1334-1347.
20. + T-cell cytokine response induces fractalkine in endothelial cells. J Virol. 2004;78:13173-13181.
21. Umehara H, Bloom ET, Okazaki T, Nagano Y, Yoshie O, Imai T. Fractalkine in vascular biology. Arterioscler Thromb Vasc Biol. 2004;24:34-40.
22. Umehara H, Imai T. Role of fractalkine in leukocyte adhesion and migration and in vascular injury. Drug News Perspect. 2001;14:460-464.
23. Haskell CA, Cleary MD, Charo IF. Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction: rapid flow arrest of CX3CR1-expressing cells is independent of G-protein activation. J Biol Chem. 1999;274:10053-10058.
24. Yoneda O, Imai T, Goda S, et al. Fractalkine-mediated endothelial cell injury by NK cells. J Immunol. 2000;164:4055-4062.
25. Peiser L, Mukhopadhyay S, Gordon S. Scavenger receptors in innate immunity. Curr Opin Immunol. 2002;14:123-128.
26. Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, Miyata M. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci U S A. 1995;92:8264-8268.
27. Janeway CA, Medzhitov R. 2002. Innate immune recognition. Annu Rev Immunol. 2002;20:197-216.
28. Bettinotti MP, Solomon S, Battiwala M, et al. T cell response against the cytomegalovirus proteins pp65 and IE1. Hum Immunol. 2003;64:S73.
29. + memory T-cell response to CMV. J Immunol. 2001;167:1151-1163.
30. + T cells dominate the memory compartments of exposed subjects. J Exp Med. 2005;202:673-685.
31. Simon CO, Holtappels R, Tervo HM, et al. CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation. J Virol. 2006;80:10436-10456.
32. Almanzar G, Schwaiger S, Jenewein B, et al. Long-term cytomegalovirus infection leads to significant changes in the composition of the T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol. 2005;79:3675-3683.
33. + T cells in healthy carriers are continuously driven to replicative exhaustion. J Immunol. 2005;175:8218-8225.
34. Trzonkowski P, Myoeliwska J, Szmit E, et al. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination: an impact of immunosenescence. Vaccine. 2003;21:3826-3836.
35. Hsue P, Hunt P, Waters D, et al. Increased carotid intima-media thickness in HIV-infected patients is associated with increased C-reactive protein levels and increased cytomegalovirus specific T cell activation. Presented at: 2006 CROI meeting #741, Denver, CO; February 6, 2006.
36. Wohl DA, Kendall MA, Owens S, et al. The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy. HIV Clin Trials. 2005;6:136-146.